世界のT細胞移植療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global T Cell Transfer Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5541
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、T細胞移植療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家、同種異系）、用途別市場規模（子供、大人、高齢者）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・T細胞移植療法の市場動向
・企業の競争状況、市場シェア
・T細胞移植療法の種類別市場規模（自家、同種異系）
・T細胞移植療法の用途別市場規模（子供、大人、高齢者）
・T細胞移植療法の北米市場規模2016-2027（アメリカ、カナダ）
・T細胞移植療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・T細胞移植療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・T細胞移植療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・T細胞移植療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Merck、Novartis、Johnson & Johnson、Glaxosmithkline、Amgen、Abbvie、Astrazeneca、Bristol-Myers Squibb、ELI Lilly）
・結論

Market Analysis and Insights: Global T Cell Transfer Therapy Market
The global T Cell Transfer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T Cell Transfer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T Cell Transfer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T Cell Transfer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T Cell Transfer Therapy market.

Global T Cell Transfer Therapy Scope and Market Size
T Cell Transfer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T Cell Transfer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Source of T-cells and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Source of T-cells
Autologous
Allogeneic

Segment by Application
Child
Adult
The Elderly

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T Cell Transfer Therapy Market Size Growth Rate by Source of T-cells: 2016 VS 2021 VS 2027
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global T Cell Transfer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Child
1.3.3 Adult
1.3.4 The Elderly
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T Cell Transfer Therapy Market Perspective (2016-2027)
2.2 T Cell Transfer Therapy Growth Trends by Regions
2.2.1 T Cell Transfer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T Cell Transfer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 T Cell Transfer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 T Cell Transfer Therapy Industry Dynamic
2.3.1 T Cell Transfer Therapy Market Trends
2.3.2 T Cell Transfer Therapy Market Drivers
2.3.3 T Cell Transfer Therapy Market Challenges
2.3.4 T Cell Transfer Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T Cell Transfer Therapy Players by Revenue
3.1.1 Global Top T Cell Transfer Therapy Players by Revenue (2016-2021)
3.1.2 Global T Cell Transfer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global T Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T Cell Transfer Therapy Revenue
3.4 Global T Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global T Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T Cell Transfer Therapy Revenue in 2020
3.5 T Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players T Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into T Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T Cell Transfer Therapy Breakdown Data by Source of T-cells
4.1 Global T Cell Transfer Therapy Historic Market Size by Source of T-cells (2016-2021)
4.2 Global T Cell Transfer Therapy Forecasted Market Size by Source of T-cells (2022-2027)

5 T Cell Transfer Therapy Breakdown Data by Application
5.1 Global T Cell Transfer Therapy Historic Market Size by Application (2016-2021)
5.2 Global T Cell Transfer Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T Cell Transfer Therapy Market Size (2016-2027)
6.2 North America T Cell Transfer Therapy Market Size by Source of T-cells
6.2.1 North America T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021)
6.2.2 North America T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027)
6.2.3 North America T Cell Transfer Therapy Market Size by Source of T-cells (2016-2027)
6.3 North America T Cell Transfer Therapy Market Size by Application
6.3.1 North America T Cell Transfer Therapy Market Size by Application (2016-2021)
6.3.2 North America T Cell Transfer Therapy Market Size by Application (2022-2027)
6.3.3 North America T Cell Transfer Therapy Market Size by Application (2016-2027)
6.4 North America T Cell Transfer Therapy Market Size by Country
6.4.1 North America T Cell Transfer Therapy Market Size by Country (2016-2021)
6.4.2 North America T Cell Transfer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe T Cell Transfer Therapy Market Size (2016-2027)
7.2 Europe T Cell Transfer Therapy Market Size by Source of T-cells
7.2.1 Europe T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021)
7.2.2 Europe T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027)
7.2.3 Europe T Cell Transfer Therapy Market Size by Source of T-cells (2016-2027)
7.3 Europe T Cell Transfer Therapy Market Size by Application
7.3.1 Europe T Cell Transfer Therapy Market Size by Application (2016-2021)
7.3.2 Europe T Cell Transfer Therapy Market Size by Application (2022-2027)
7.3.3 Europe T Cell Transfer Therapy Market Size by Application (2016-2027)
7.4 Europe T Cell Transfer Therapy Market Size by Country
7.4.1 Europe T Cell Transfer Therapy Market Size by Country (2016-2021)
7.4.2 Europe T Cell Transfer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T Cell Transfer Therapy Market Size (2016-2027)
8.2 Asia-Pacific T Cell Transfer Therapy Market Size by Source of T-cells
8.2.1 Asia-Pacific T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021)
8.2.2 Asia-Pacific T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027)
8.2.3 Asia-Pacific T Cell Transfer Therapy Market Size by Source of T-cells (2016-2027)
8.3 Asia-Pacific T Cell Transfer Therapy Market Size by Application
8.3.1 Asia-Pacific T Cell Transfer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T Cell Transfer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T Cell Transfer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific T Cell Transfer Therapy Market Size by Region
8.4.1 Asia-Pacific T Cell Transfer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T Cell Transfer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T Cell Transfer Therapy Market Size (2016-2027)
9.2 Latin America T Cell Transfer Therapy Market Size by Source of T-cells
9.2.1 Latin America T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021)
9.2.2 Latin America T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027)
9.2.3 Latin America T Cell Transfer Therapy Market Size by Source of T-cells (2016-2027)
9.3 Latin America T Cell Transfer Therapy Market Size by Application
9.3.1 Latin America T Cell Transfer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America T Cell Transfer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America T Cell Transfer Therapy Market Size by Application (2016-2027)
9.4 Latin America T Cell Transfer Therapy Market Size by Country
9.4.1 Latin America T Cell Transfer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America T Cell Transfer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T Cell Transfer Therapy Market Size (2016-2027)
10.2 Middle East & Africa T Cell Transfer Therapy Market Size by Source of T-cells
10.2.1 Middle East & Africa T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021)
10.2.2 Middle East & Africa T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027)
10.2.3 Middle East & Africa T Cell Transfer Therapy Market Size by Source of T-cells (2016-2027)
10.3 Middle East & Africa T Cell Transfer Therapy Market Size by Application
10.3.1 Middle East & Africa T Cell Transfer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T Cell Transfer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T Cell Transfer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa T Cell Transfer Therapy Market Size by Country
10.4.1 Middle East & Africa T Cell Transfer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T Cell Transfer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche T Cell Transfer Therapy Introduction
11.1.4 Roche Revenue in T Cell Transfer Therapy Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck T Cell Transfer Therapy Introduction
11.2.4 Merck Revenue in T Cell Transfer Therapy Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis T Cell Transfer Therapy Introduction
11.3.4 Novartis Revenue in T Cell Transfer Therapy Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson T Cell Transfer Therapy Introduction
11.4.4 Johnson & Johnson Revenue in T Cell Transfer Therapy Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline T Cell Transfer Therapy Introduction
11.5.4 Glaxosmithkline Revenue in T Cell Transfer Therapy Business (2016-2021)
11.5.5 Glaxosmithkline Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen T Cell Transfer Therapy Introduction
11.6.4 Amgen Revenue in T Cell Transfer Therapy Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie T Cell Transfer Therapy Introduction
11.7.4 Abbvie Revenue in T Cell Transfer Therapy Business (2016-2021)
11.7.5 Abbvie Recent Development
11.8 Astrazeneca
11.8.1 Astrazeneca Company Details
11.8.2 Astrazeneca Business Overview
11.8.3 Astrazeneca T Cell Transfer Therapy Introduction
11.8.4 Astrazeneca Revenue in T Cell Transfer Therapy Business (2016-2021)
11.8.5 Astrazeneca Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb T Cell Transfer Therapy Introduction
11.9.4 Bristol-Myers Squibb Revenue in T Cell Transfer Therapy Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 ELI Lilly
11.10.1 ELI Lilly Company Details
11.10.2 ELI Lilly Business Overview
11.10.3 ELI Lilly T Cell Transfer Therapy Introduction
11.10.4 ELI Lilly Revenue in T Cell Transfer Therapy Business (2016-2021)
11.10.5 ELI Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global T Cell Transfer Therapy Market Size Growth Rate by Source of T-cells (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global T Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global T Cell Transfer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global T Cell Transfer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global T Cell Transfer Therapy Market Share by Regions (2016-2021)
Table 8. Global T Cell Transfer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global T Cell Transfer Therapy Market Share by Regions (2022-2027)
Table 10. T Cell Transfer Therapy Market Trends
Table 11. T Cell Transfer Therapy Market Drivers
Table 12. T Cell Transfer Therapy Market Challenges
Table 13. T Cell Transfer Therapy Market Restraints
Table 14. Global T Cell Transfer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global T Cell Transfer Therapy Market Share by Players (2016-2021)
Table 16. Global Top T Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Transfer Therapy as of 2020)
Table 17. Ranking of Global Top T Cell Transfer Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by T Cell Transfer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players T Cell Transfer Therapy Product Solution and Service
Table 21. Date of Enter into T Cell Transfer Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 24. Global T Cell Transfer Therapy Revenue Market Share by Source of T-cells (2016-2021)
Table 25. Global T Cell Transfer Therapy Forecasted Market Size by Source of T-cells (2022-2027) (US$ Million)
Table 26. Global T Cell Transfer Therapy Revenue Market Share by Source of T-cells (2022-2027) & (US$ Million)
Table 27. Global T Cell Transfer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global T Cell Transfer Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global T Cell Transfer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global T Cell Transfer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 32. North America T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 33. North America T Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America T Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America T Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America T Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 38. Europe T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 39. Europe T Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe T Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe T Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe T Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 44. Asia-Pacific T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 45. Asia-Pacific T Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific T Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific T Cell Transfer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific T Cell Transfer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 50. Latin America T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 51. Latin America T Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America T Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America T Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America T Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa T Cell Transfer Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 56. Middle East & Africa T Cell Transfer Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 57. Middle East & Africa T Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa T Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa T Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa T Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche T Cell Transfer Therapy Product
Table 64. Roche Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck T Cell Transfer Therapy Product
Table 69. Merck Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis T Cell Transfer Therapy Product
Table 74. Novartis Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson T Cell Transfer Therapy Product
Table 79. Johnson & Johnson Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Glaxosmithkline Company Details
Table 82. Glaxosmithkline Business Overview
Table 83. Glaxosmithkline T Cell Transfer Therapy Product
Table 84. Glaxosmithkline Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 85. Glaxosmithkline Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen T Cell Transfer Therapy Product
Table 89. Amgen Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Abbvie Company Details
Table 92. Abbvie Business Overview
Table 93. Abbvie T Cell Transfer Therapy Product
Table 94. Abbvie Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 95. Abbvie Recent Development
Table 96. Astrazeneca Company Details
Table 97. Astrazeneca Business Overview
Table 98. Astrazeneca Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 99. Astrazeneca Recent Development
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb T Cell Transfer Therapy Product
Table 103. Bristol-Myers Squibb Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 104. Bristol-Myers Squibb Recent Development
Table 105. ELI Lilly Company Details
Table 106. ELI Lilly Business Overview
Table 107. ELI Lilly T Cell Transfer Therapy Product
Table 108. ELI Lilly Revenue in T Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 109. ELI Lilly Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T Cell Transfer Therapy Market Share by Source of T-cells: 2020 VS 2027
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global T Cell Transfer Therapy Market Share by Application: 2020 VS 2027
Figure 5. Child Case Studies
Figure 6. Adult Case Studies
Figure 7. The Elderly Case Studies
Figure 8. T Cell Transfer Therapy Report Years Considered
Figure 9. Global T Cell Transfer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global T Cell Transfer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global T Cell Transfer Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global T Cell Transfer Therapy Market Share by Regions (2022-2027)
Figure 13. Global T Cell Transfer Therapy Market Share by Players in 2020
Figure 14. Global Top T Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Transfer Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by T Cell Transfer Therapy Revenue in 2020
Figure 16. Global T Cell Transfer Therapy Revenue Market Share by Source of T-cells (2016-2021)
Figure 17. Global T Cell Transfer Therapy Revenue Market Share by Source of T-cells (2022-2027)
Figure 18. North America T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America T Cell Transfer Therapy Market Share by Source of T-cells (2016-2027)
Figure 20. North America T Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 21. North America T Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 22. United States T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe T Cell Transfer Therapy Market Share by Source of T-cells (2016-2027)
Figure 26. Europe T Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 27. Europe T Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 28. Germany T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific T Cell Transfer Therapy Market Share by Source of T-cells (2016-2027)
Figure 36. Asia-Pacific T Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific T Cell Transfer Therapy Market Share by Region (2016-2027)
Figure 38. China T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America T Cell Transfer Therapy Market Share by Source of T-cells (2016-2027)
Figure 46. Latin America T Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 47. Latin America T Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 48. Mexico T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa T Cell Transfer Therapy Market Share by Source of T-cells (2016-2027)
Figure 52. Middle East & Africa T Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa T Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 54. Turkey T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE T Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Roche Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 61. Glaxosmithkline Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 63. Abbvie Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 64. Astrazeneca Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 66. ELI Lilly Revenue Growth Rate in T Cell Transfer Therapy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の養子細胞移植療法市場規模・現状・予測（2021年-2027年）

Global Adoptive Cell Transfer Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0108 2021年4月 159Pages
QYResearch社発行の本調査資料では、養子細胞移植療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NK、LAK、DC、CIK、CTL、TIL、TCR-T、CAR-T）、用途別市場規模（急性リンパ性白血病、NHL、黒色腫、膀胱がん、肺が...

世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Animal Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0344 2021年4月 98Pages
QYResearch社発行の本調査資料では、動物用幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（犬用幹細胞治療、馬用幹細胞治療、その他動物）、用途別市場規模（獣医病院、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Rheumatoid Arthritis Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5046 2021年4月 93Pages
QYResearch社発行の本調査資料では、関節リウマチ幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種間葉系幹細胞、骨髄移植、脂肪組織幹細胞）、用途別市場規模（病院、外来手術センター、専門診療所）、主要地域別市場規模（北米、アメ...

世界の犬幹細胞療法市場規模・現状・予測（2021年-2027年）

Global Canine Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1084 2021年4月 92Pages
QYResearch社発行の本調査資料では、犬幹細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種幹細胞、自家幹細胞）、用途別市場規模（獣医病院、獣医クリニック、獣医研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の脂肪由来幹細胞（ADSC）治療市場規模・現状・予測（2021年-2027年）

Global Adipose Derived Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0104 2021年4月 129Pages
QYResearch社発行の本調査資料では、脂肪由来幹細胞（ADSC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞、同種幹細胞）、用途別市場規模（治療、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2021-2027
QYR2104Z5442 2021年4月 95Pages
QYResearch社発行の本調査資料では、変形性関節症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（変形性関節症（詳細不明）、変形性膝関節症、肩変形性関節症、股関節変形性関節症）、主要地域別市...

世界の脂肪組織由来幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Adipose Tissue-derived Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0105 2021年4月 133Pages
QYResearch社発行の本調査資料では、脂肪組織由来幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞、同種幹細胞）、用途別市場規模（治療、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年）

Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2021-2027
QYR2104Z1099 2021年4月 94Pages
QYResearch社発行の本調査資料では、多発性骨髄腫用CART細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（多発性骨髄腫、難治性/再発性多発性骨髄腫）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年）

世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年）

Global Cancer Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1071 2021年4月 92Pages
QYResearch社発行の本調査資料では、がん幹細胞（CSC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）、用途別市場規模（病院、クリニック、医学研究機関、その他）、主要地域別市...

世界の養子細胞移植療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Adoptive Cell Transfer Therapy Market The global Adoptive Cell Transfer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の犬幹細胞療法市場規模・現状・予測（2021年-2027年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilica…
世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年） Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …